M42 Health
Ziyad A. Kabli is currently the Chief Operating Officer for the Middle East and Asia at M42 Health, a position held since January 2025. Prior to this role, Ziyad served as the Regional Vice President and Managing Director for Diaverum, the largest private Renal Care service provider in the Middle East, from January 2014 to December 2024. Ziyad's extensive experience also includes serving as Chief Supply Chain Officer at SADAFCO, overseeing strategic supply chain management across multiple locations in Saudi Arabia and the Gulf from February 2007 to December 2013. Earlier in Ziyad's career, roles at Unilever included Customer Service Excellence Program Director and various management positions in supply chain and manufacturing from August 1999 to December 2006. Ziyad holds a BSc in Applied Chemical Engineering from King Fahd University of Petroleum & Minerals and completed a program at Duke University Sanford School of Public Policy in 2013.
This person is not in any teams
This person is not in any offices
M42 Health
14 followers
M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement. The company is seeking to transform lives through innovative clinical solutions that can solve the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is transforming the traditional healthcare ecosystem and delivering the highest level of precise, patient-centric, and preventative care. M42 has over 20,000 employees and more than 450 facilities in 26 countries around the world. M42 owns a wide portfolio of assets that includes Amana Healthcare, Biogenix Labs, Danat Al Emarat, Diaverum, HealthPoint Hospital, the HealthPlus network of specialty centers, Moorfields Eye Hospital Abu Dhabi, Imperial College London Diabetes Centre, Insights Research Organization & Solutions (IROS), Omics Center of Excellence and National Reference Laboratory, among others.